Effect of Ligustrazine on Endometrium Injury of Thin Endometrium Rats

Abstract EN

The purpose of this experiment is to establish a rat model of thin endometrium and to explore the effect of ligustrazine on the thin endometrium of rats.

The thin endometrium model was made by using infusing absolute ethyl alcohol into the uterine cavity.

The thickness of endometrium was measured.

Hematoxylin-Eosin (HE) staining was used to observe the histopathological changes of endometrium.

The mRNA levels of VEGF, VEGFR-2, PI3K, and AKT were detected by RT-PCR.

Western blotting was used to detect the levels of VEGF, VEGFR-2, PI3K, and AKT in endometrial tissue.

The thickness of endometrium in the model group was significantly thinner than that in the control group.

Compared with the model group, the thickness of endometrium in ligustrazine group was increased.

HE staining shown that ligustrazine restored the histopathological changes of endometrium.

RT-PCR and Western Blotting results showed that the mRNA and protein levels of VEGF, VEGFR-2, PI3K, and AKT in the model group were significantly decreased compared with the control group, while ligustrazine restored the changes.

Ligustrazine can improve the morphology of endometrium, can promote the growth of endometrium, and has obvious therapeutic effect.

Its mechanism is related to the activation of PI3K/Akt signaling pathway through upregulation of VEGF and VEGFR-2 expression to induce the repair of thin endometrium in rats.